Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63,223,223
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
13,036,758
-
Shares change
-
+27,138
-
Total reported value, excl. options
-
$350,676,095
-
Value change
-
-$6,970,436
-
Number of buys
-
34
-
Number of sells
-
-30
-
Price
-
$26.9
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q3 2021
75 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q3 2021.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,036,758 shares
of 63,223,223 outstanding shares and own 20.62% of the company stock.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (1,857,517 shares), VANGUARD GROUP INC (1,541,576 shares), PERCEPTIVE ADVISORS LLC (1,235,886 shares), NEXT CENTURY GROWTH INVESTORS LLC (1,083,383 shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (777,373 shares), BlackRock Inc. (686,230 shares), JANUS HENDERSON GROUP PLC (655,926 shares), FMR LLC (608,665 shares), TimesSquare Capital Management, LLC (568,980 shares), and Sectoral Asset Management Inc (541,022 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.